Singapore markets closed

CHRS Dec 2023 17.500 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.10000.0000 (0.00%)
As of 03:13PM EDT. Market open.
Full screen
Previous close0.1000
Expiry date2023-12-15
Day's range0.1000 - 0.1000
Contract rangeN/A
Open interest117
  • Zacks

    Coherus (CHRS) Gets CRL for Udenyca Onbody, Shares Down

    Coherus (CHRS) gets CRL for the biologics license application supplement for Udenyca Onbody, an on-body injector presentation of Udenyca.

  • Motley Fool

    Why Coherus BioSciences Stock Was Plunging This Week

    Unfortunately for shareholders of Coherus BioSciences (NASDAQ: CHRS), that's what happened to their company after market hours last Friday. Following that, its stock price was falling by 10% week to date as of early Friday morning, according to data compiled by S&P Global Market Intelligence. Among these incoming S&P SmallCap 600 constituents are pizza slinger Papa John's International, storied athletic apparel retailer Foot Locker, and JetBlue Airways.

  • Motley Fool

    Why Coherus BioSciences Stock Popped Today

    Shares of Coherus BioSciences (NASDAQ: CHRS) soared 17.7% on Thursday, according to data provided by S&P Global Market Intelligence, after the biotech company announced better-than-expected quarterly results. Coherus' net revenue climbed a whopping 81% year over year to $58.7 million, translating to an adjusted net loss of $32.8 million, or $0.38 per share. Analysts, on average, were anticipating a wider net loss of $0.48 per share on lower revenue of $50.5 million.